abstract |
The present invention relates to a CNNM4 inhibitor for use in the treatment of acute or chronic liver, kidney and/or lung disease in a subject, and a pharmaceutical composition comprising a therapeutically effective amount of a CNNM4 inhibitor and a pharmaceutically acceptable excipient or carrier. it's about Furthermore, the present invention relates to methods of diagnosing liver disease, kidney disease, or lung disease in a subject, and in vitro methods for identifying compounds potentially useful for reducing CNNM4-mediated diseases or conditions induced in cells. |